| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/15/2009 | US7589069 Replication-competent anti-cancer vectors |
| 09/15/2009 | US7588938 Neural stem cell-collagen-bioreactor system to construct a functional embryonic brain-like tissue |
| 09/15/2009 | US7588937 Using nutrient broth comprising fibroblast growth factor for use in propagation of nervous system tissues |
| 09/15/2009 | US7588936 Making dental pulp, predentin, dentin without the need for purification and expansion of a population of cells |
| 09/15/2009 | US7588935 Comprises a cDNA sequence reverse transcribed from RNA of Cymbidium mosaic virus (CymMV); Virus induced gene silencing; viral vector whose transcripts induce gene inactivation in an orchid |
| 09/15/2009 | US7588927 novel protease called SENP1, which is active against sentrin-modified proteins in vivo |
| 09/15/2009 | US7588925 Isolated from Aspergillus niger; used in industrial processes and methods of diagnosing fungal infections; reducing phospholipid content of an edible oil; baked goods |
| 09/15/2009 | US7588922 Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use |
| 09/15/2009 | US7588916 Expression vector comprising nucleotide sequences coding g protein coupled receptor for use in identifying modulators of taste preception; artificial sweeteners and enhancement of food flavors |
| 09/15/2009 | US7588900 Mammalian sweet and amino acid heterodimeric taste receptors |
| 09/15/2009 | US7588888 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
| 09/15/2009 | US7588769 Recombinant influenza virus comprising a mutant membrane protein gene, e.g., a mutant integral membrane protein gene such as a mutant type III integral membrane protein gene, which does not encode a functional membrane protein or a functional portion thereof; use in gene therapy |
| 09/15/2009 | US7588761 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 09/15/2009 | CA2421683C Microparticles for delivery of the heterologous nucleic acids |
| 09/15/2009 | CA2369616C Somatic transgene immunization and related methods |
| 09/15/2009 | CA2348828C Genomic and complete cdna sequences of apm1 and biallelic markers thereof |
| 09/15/2009 | CA2331471C Compounds with an antioxidant activity, compositions useful as food integrators containing them and process for their preparation |
| 09/15/2009 | CA2156272C Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 09/15/2009 | CA2032158C Multivalent repressor of gene function |
| 09/11/2009 | WO2009111778A2 Lymph nodes as a site for regeneration |
| 09/11/2009 | WO2009111723A1 Electrowetting microarray printing system and methods for bioactive tissue construct manufacturing |
| 09/11/2009 | WO2009111691A2 Combination therapy with c-met and egfr antagonists |
| 09/11/2009 | WO2009111635A2 Dithiol compounds, derivatives, and uses therefor |
| 09/11/2009 | WO2009111633A2 Mercaptan and seleno-mercaptan compounds and methods of using them |
| 09/11/2009 | WO2009111599A2 Plasmodium malariae and plasmodium ovale genes and uses thereof |
| 09/11/2009 | WO2009111396A1 Dendritic cell precursor populations, dendritic cell populations derived therefrom and uses thereof |
| 09/11/2009 | WO2009111338A1 A system and process for separating a material |
| 09/11/2009 | WO2009111087A1 Novel use of basic fibroblast growth factor in the de-differentiation of animal connective tissue cells |
| 09/11/2009 | WO2009111030A1 Use of mesenchymal stem cells for treating genetic diseases and disorders |
| 09/11/2009 | WO2009111022A1 Hydrophobically modified cellulose ether derivatives for cell culture and release |
| 09/11/2009 | WO2009111021A1 Coated cell culture surfaces and methods for producing the same |
| 09/11/2009 | WO2009110656A1 The vector containing erythropoietin gene, the transformed silkworm by the vector, the process for producing erythropoietin from the silkworm's cocoon, and erythropoietin obtained thereby |
| 09/11/2009 | WO2009110466A1 Genes that increase the production of oil in plants, and method of using the same |
| 09/11/2009 | WO2009110215A1 Method for induction of ciliated cell differentiation |
| 09/11/2009 | WO2009110113A1 Therapeutic agent for nerve injury and method for treating nerve injury |
| 09/11/2009 | WO2009109604A1 Method for detection of parvovirus b19 in blood or bone marrow |
| 09/11/2009 | WO2009109500A1 Polypeptides having lipase activity and polynucleotides encoding same |
| 09/11/2009 | WO2009109377A1 Cell line from rousettus as host cell for pathogen amplification |
| 09/11/2009 | WO2009109123A1 An artificial synthesized insecticidal gene and the protein encoded by same and uses thereof |
| 09/11/2009 | WO2009109054A1 Diacylglycerol acyltransferases from flax |
| 09/11/2009 | WO2009109051A1 Diacyglycerol acyltransferases from flax |
| 09/11/2009 | WO2009076638A3 Compositions and methods relating to characterization and therapeutic application of pristine stem cells |
| 09/11/2009 | WO2009059233A3 Near-infrared electromagnetic modification of cellular steady-state membrane potentials |
| 09/11/2009 | WO2009031127A3 Non-invasive automated cell proliferation apparatus |
| 09/11/2009 | WO2004105576A3 Tissue harvesting device and method |
| 09/11/2009 | CA2749142A1 Cell, method and kit for conducting an assay for neutralizing antibodies |
| 09/11/2009 | CA2728285A1 Engineered co2 fixing microorganisms producing carbon-based products of interest |
| 09/11/2009 | CA2718058A1 Cell line from rousettus as host cell for pathogen amplification |
| 09/11/2009 | CA2717819A1 Diacylglycerol acyltransferases from flax |
| 09/11/2009 | CA2717818A1 Diacylglycerol acyltransferases from flax |
| 09/11/2009 | CA2717727A1 Gene that increases production of plant fat-and-oil and method for using the same |
| 09/11/2009 | CA2717498A1 Use of mesenchymal stem cells for treating genetic diseases and disorders |
| 09/11/2009 | CA2716851A1 Combination therapy with c-met and egfr antagonists |
| 09/11/2009 | CA2715829A1 Polypeptides having lipase activity and polynucleotides encoding same |
| 09/10/2009 | US20090229016 Cambium/xylem-preferred promoters and uses thereof |
| 09/10/2009 | US20090229013 Geminivirus resistant transgenic plants |
| 09/10/2009 | US20090229011 Disease-resistant plants and method of constructing the same |
| 09/10/2009 | US20090229009 Polynucleotides and methods for improving plants |
| 09/10/2009 | US20090229008 Transcription factors |
| 09/10/2009 | US20090229006 Herbicide resistant plants |
| 09/10/2009 | US20090228997 Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof |
| 09/10/2009 | US20090228995 Polymorphisms and Haplotypes of the Alpha 2C Adrenergic Receptor Gene |
| 09/10/2009 | US20090228994 Antibody Composition-Producing Cell |
| 09/10/2009 | US20090228993 Transgenic Pig With Altered Incretin Function |
| 09/10/2009 | US20090228105 Artificial cartilage containing chondrocytes obtained from costal cartilage and preparation process thereof |
| 09/10/2009 | US20090227833 Pipette aspiration device |
| 09/10/2009 | US20090227778 Stable cell lines expressing herg1a and herg1b |
| 09/10/2009 | US20090227770 Polypeptide carrier protein |
| 09/10/2009 | US20090227678 Process for obtaining lipid form cells |
| 09/10/2009 | US20090227664 Expression Vectors Able to Elicit Improved Immune Response and Methods of Using Same |
| 09/10/2009 | US20090227663 Inhibition of tumor growth and invasion by anti matrix metalloproteinases dnazymes |
| 09/10/2009 | US20090227662 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
| 09/10/2009 | US20090227659 Nucleolar targeting of therapeutics against HIV |
| 09/10/2009 | US20090227658 Methods and compositions for immunization against hiv |
| 09/10/2009 | US20090227655 Nonviral vectors for delivering polynucleotides to target tissue |
| 09/10/2009 | US20090227652 Indole derivatives and methods of using the same |
| 09/10/2009 | US20090227571 Androgen Receptor Modulator Compounds and Methods |
| 09/10/2009 | US20090227555 Novel Pyridine Compounds |
| 09/10/2009 | US20090227531 Transcription factors in neuronal dendrites-dendritic protein synthesis and cell death |
| 09/10/2009 | US20090227517 Myostatin binding agents |
| 09/10/2009 | US20090227509 Modulation of hiv replication by rna interference |
| 09/10/2009 | US20090227502 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 09/10/2009 | US20090227499 Soluble gp130 molecule variants useful as a medicament |
| 09/10/2009 | US20090227497 Variant activin receptor polypeptides and uses thereof |
| 09/10/2009 | US20090227470 Selection of biocatalysts for chemical synthesis |
| 09/10/2009 | US20090227032 Nuclear reprogramming factor and induced pluripotent stem cells |
| 09/10/2009 | US20090227031 Cells for adenovirus vector and protein production |
| 09/10/2009 | US20090227030 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/10/2009 | US20090227028 Biological control of pathogenicity in microbes that use alpha, beta unsaturated fatty acid signal molecules |
| 09/10/2009 | US20090227027 Coated cell culture surfaces and methods thereof |
| 09/10/2009 | US20090227026 Tissue engineering scaffolds |
| 09/10/2009 | US20090227025 Ex vivo human lung/immune system model using tissue engineering for studying microbial pathogens with lung tropism |
| 09/10/2009 | US20090227024 Modified polysaccharide for cell culture and release |
| 09/10/2009 | US20090227023 DE-DIFFERENTIATION OF ASTROCYTES INTO NEURAL STEM CELL USING Shh |
| 09/10/2009 | US20090227022 Growth factor homolog zvegf4 |
| 09/10/2009 | US20090227021 Purified mammalian ctla-8 antigens and related reagents |
| 09/10/2009 | US20090227020 Immunogenic peptides |
| 09/10/2009 | US20090227019 Hematopoietic stem cell identification and isolation |
| 09/10/2009 | US20090227018 Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction |
| 09/10/2009 | US20090227017 Nucleic acids encoding receptor for il-17 homologous polypeptides and uses thereof |